Adonis Georgiadis’ Leadership: Multinational Clinical Trials and Health Strategy in the EU

Adonis Georgiadis and Ensuring Drug Supply Security

During the informal EU Health Ministers’ meeting on September 15–16 in Copenhagen, chaired by Danish Minister Sophie Lohde, Adonis Georgiadis highlighted the critical importance of drug supply security. Recent European Commission data indicate that approximately 20% of medicines face recurring shortages, underscoring the need for collaboration and data sharing between member states.

Georgiadis warned that the implementation of the new urban wastewater directive poses serious risks to drug availability, potentially causing companies to leave the EU. Greece, however, has precise demand estimates for every pharmaceutical product, making it a model for other member states.

Greece as a Model for Multinational Clinical Trials

Georgiadis emphasized the strategic role of multinational clinical trials in health innovation. These trials:

• Bring new treatments closer to patients.
• Strengthen EU competitiveness on a global scale.
• Ensure smaller markets also benefit from innovation.

EU data show that countries with strong, coordinated frameworks for clinical trials experience up to 30% faster approval of new medicines, highlighting the strategic importance of Greece’s approach.

Strategic Response to Antimicrobial Resistance through 2030

Greece leads in combating antimicrobial resistance with the National Action Plan “One Health”, coordinated among the Ministry of Health, Hellenic National Public Health Organization (EODY), Ministry of Rural Development, and Ministry of Environment. The Plan:

• Focuses on four main priorities.
• Includes measurable targets through 2030.
• Fully aligns with the 2023 European Council recommendations.

Indicators show that countries with comprehensive plans reduce the emergence of multi-resistant strains by 25–40%.

Coordinated EU Policy: From Data to Joint Procurement

Secretary-General Dr. Aris Aggelis emphasized the need for accurate and timely data to ensure effective prediction of drug shortages. Enhanced collaboration between member states provides:

• More precise demand forecasting.
• Faster response to crises.
• Effective use of multi-supplier public procurement models.

With its national e-prescription system, Greece sets a standard in leveraging data for monitoring pharmaceutical stock levels.

Greece Recognized Internationally: WHO Europe Visit and Global Collaboration

On the sidelines of the Council, the Minister and Secretary-General visited the WHO Regional Office for Europe and met with Hans Kluge. Greece is acknowledged as a leader in shaping EU health strategy, reinforcing innovation, drug security, and competitiveness on a global stage.

The decisive presence of Adonis Georgiadis at the informal EU meeting demonstrates that Greece is not merely an observer, but a pioneer in shaping EU health policy, setting benchmarks for innovation, drug availability, and scientific excellence.

Source: pagenews.gr